Use of the bioMérieux VIDAS® troponin I ultra assay for the diagnosis of myocardial infarction and detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome

Clinica Chimica Acta

Volumn 390, Issue 1-2, 2008, Pages 72-75

  Apple, Fred S ^a   Smith, Stephen W ^a   Pearce, Lesly A ^b   Ler, Ranka ^a   Murakami, MaryAnn M ^a   Benoit, Marie Odile ^c   Levy, Camille ^c   Dumas, Catherine ^c   Paul, Jean Louis ^c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Biostatistical Consulting   (United States)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Biomarkers; Cardiac troponin; Myocardial infarction; Risk stratification

Indexed keywords

TROPONIN I;

ACUTE CORONARY SYNDROME; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY;

ACUTE CORONARY SYNDROME; ELECTROCARDIOGRAPHY; HUMANS; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TROPONIN I;

EID: 39649089133     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.12.016     Document Type: Article

References (15)

1. Thygesen K., Alpert J.S., White H.D., Jaffe A.S., Apple F.S., Galvani M., et al. On behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the redefinition of myocardial infarction. Eur Heart J 28 (2007) 2525-2538
2. Morrow D.A., Cannon C.P., Jesse R.L., Newby L.K., Ravkilde J., Storrow A.B., et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 53 (2007) 552-574
3. Gibler W.B., Canon C.P., Blomkains A.L., Char D.M., Drew B.J., Hollander J.E., et al. Practical implementation of the guidelines for unstable angina non-ST-segment elevation myocardial infarction in the emergency department. Ann Emerg Med 46 (2005) 185-197
4. Heidenreich P.A., Alloggiamento T., Melsop K., McDonald K.M., Go A.S., and Hlatky M.A. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol 38 (2001) 478-485
5. Kavsak P.A., MacRae A.R., Lustig V., Bhargava R., Vandersluis R., Palomaki G.E., et al. The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction. Am Heart J 152 (2006) 118-125
6. Lin J.C., Apple F.S., Murakami M.M., and Luepker R.V. Rates of positive cardiac troponin I and creatine kinase MB among patients hospitalized for suspected acute coronary syndromes. Clin Chem 50 (2004) 333-338
7. Venge P., Lagerquist B., Diderholm E., Lindahl B., Wallentin L., and on behalf of the FRISC II study group. Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy). Am J Cardiol 89 (2002) 1035-1041
8. Tucker J.F., Collins R.A., Anderson A.J., Hauser J., Kalas J., and Apple F.S. Early diagnostic efficacy of cardiac troponin I and T for acute myocardial infarction. Acad Emerg Med 4 (1997) 13-21
9. Zimmerman J., Fromm R., Meyer D., Boudreaux A., Wu C.C.C., Smalling R., et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation 99 (1999) 1671-1678
10. Jaffe A.S., Babuin L., and Apple F.S. Biomarkers in acute cardiac disease. J Am Coll Cardiol 48 (2006) 1-11
11. Apple F.S., and Murakami M.M. Cardiac troponin and creatine kinase MB monitoring during in-hospital myocardial reinfarction. Clin Chem 51 (2005) 460-463
12. Apple F.S., Jesse R.L., Newby L.K., Wu A.H.B., and Christenson R.H. National Academy of Clinical Biochemistry and IFCC committee for standardization of markers of cardiac damage laboratory medicine practice guidelines: analytical issues for biochemical markers for acute coronary syndrome. Clin Chem 53 (2007) 547-551
13. Zethelius B., Johnston N., and Venge P. Troponin I as a predictor of coronary heart disease and mortality in 70 year old men: a community-based cohort study. Circulation 113 (2006) 1071-1078
14. Apple F.S., Pearce L.A., Doyle P.J., Otto A.P., and Murakami M.M. Cardiac troponin risk stratification based on 99th percentile reference cutoff in patients with ischemic symptoms suggestive of acute coronary syndrome: influence of estimated glomerular filtration rates. Am J Clin Pathol 127 (2007) 589-603
15. Newby L.K., Storrow A.B., Gibler W.B., Garvey J.L., Tucker J.F., Kaplan A.L., et al. Bedside multimarker testing for risk stratification in chest paint units: the chest pain evaluation by creatine kinase-MB, myoglobin and troponin I (CHECKMATE) study. Circulation 103 (2001) 1832-1837